Literature DB >> 16125475

SOCS3 was induced by hypoxia and suppressed STAT3 phosphorylation in pulmonary arterial smooth muscle cells.

Li Bai1, Zubin Yu, Guisheng Qian, Pin Qian, Jinjun Jiang, Guansong Wang, Chunxue Bai.   

Abstract

Recently identified suppressors of cytokine signaling (SOCS) have been proposed as negative regulators of cytokine signaling, which have distinct mechanisms of inhibiting JAK-STAT pathway. In this study, using cultures of rat primary pulmonary vascular smooth muscle cells (PASMC), we found that hypoxia induced strongly STAT3 phosphorylation by up to four-fold. At the same time, mRNA for the endogenous cytokine signaling repressor SOCS3, but not SOCS1, was markedly induced in PASMC as early as 2h following hypoxic stimulation. Furthermore, forced expression of SOCS3 gene suppressed tyrosine phosphorylation of STAT3 and transcription of c-myc gene by more than 70% and 60% in PASMC under hypoxic conditions, respectively. Additionally, we showed here that hypoxia enhanced nearly two-fold increase of PASMC proliferation and overexpression of SOCS3 gene downregulated hypoxia-induced PASMC proliferation by about 50%. The finding suggest that STAT3-dependent pathway is involved in the activation and proliferation of PASMC stimulated by hypoxia, and SOCS3 is a rapidly hypoxia-inducible gene and acts to inhibit activation of cellular signaling pathway in a classical negative feedback loop.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125475     DOI: 10.1016/j.resp.2005.07.001

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  8 in total

1.  Rab1 GTPase regulates phenotypic modulation of pulmonary artery smooth muscle cells by mediating the transport of angiotensin II type 1 receptor under hypoxia.

Authors:  Hongjin Yin; Qi Li; Guisheng Qian; Yaoli Wang; Yuncheng Li; Guangyu Wu; Guansong Wang
Journal:  Int J Biochem Cell Biol       Date:  2010-11-21       Impact factor: 5.085

2.  Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in hepatocellular carcinoma.

Authors:  Wen-Yong Wu; Jun Li; Zheng-Sheng Wu; Chang-LE Zhang; Xiang-Ling Meng; Peter E Lobie
Journal:  Exp Ther Med       Date:  2011-04-11       Impact factor: 2.447

3.  Upregulation of Oct-4 isoforms in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension.

Authors:  Amy L Firth; Weijuan Yao; Carmelle V Remillard; Aiko Ogawa; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-02-05       Impact factor: 5.464

4.  Matrix Hyaluronic Acid and Hypoxia Influence a CD133+ Subset of Patient-Derived Glioblastoma Cells.

Authors:  Jee-Wei Emily Chen; Sarah Leary; Victoria Barnhouse; Jann N Sarkaria; Brendan A C Harley
Journal:  Tissue Eng Part A       Date:  2021-12-27       Impact factor: 4.080

5.  Molecular characterization and expression of suppressor of cytokine signaling (SOCS) 1, 2 and 3 under acute hypoxia and reoxygenation in pufferfish, Takifugu fasciatus.

Authors:  Dan Wang; Xin Wen; Xinyu Zhang; Yadong Hu; Xinru Li; Wenxu Zhu; Tao Wang; Shaowu Yin
Journal:  Genes Genomics       Date:  2018-07-23       Impact factor: 1.839

6.  Nur77 suppresses pulmonary artery smooth muscle cell proliferation through inhibition of the STAT3/Pim-1/NFAT pathway.

Authors:  Yan Liu; Jian Zhang; Bing Yi; Ming Chen; Jia Qi; You Yin; Xiaotong Lu; Jean-Francois Jasmin; Jianxin Sun
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

7.  SOCS3 inhibiting migration of A549 cells correlates with PYK2 signaling in vitro.

Authors:  Siyang Zhang; Dawei Guo; Lili Jiang; Qingfu Zhang; Xueshan Qiu; Enhua Wang
Journal:  BMC Cancer       Date:  2008-05-28       Impact factor: 4.430

8.  Effects of cyclic strain and growth factors on vascular smooth muscle cell responses.

Authors:  Soujanya Kona; Prithiviraj Chellamuthu; Hao Xu; Seth R Hills; Kytai Truong Nguyen
Journal:  Open Biomed Eng J       Date:  2009-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.